STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Healthcare Pharmaceuticals
chemistry-2

Telomir Pharmaceuticals Unveils Groundbreaking Progeria Treatment in Preclinical Study

byLuca Blaumann
January 7, 2025
in Pharmaceuticals, Small-Cap
Reading Time: 3 mins read
Share on TwitterShare on LinkedIn

Novel Therapy Shows Promise in Restoring Lifespan and Addressing Accelerated Aging

Telomir Pharmaceuticals (TELO), a leader in age-reversal science, has announced promising results from a preclinical study of Telomir-1, a potential therapy targeting the accelerated aging associated with progeria. Conducted in collaboration with Nagi Bioscience SA, the study utilized C. elegans (nematode) models to demonstrate that Telomir-1 effectively restores shortened lifespan and normalizes aging processes.

Key Findings from the Study

The study focused on nematodes with a mutation in the wrn-1 gene, analogous to the human gene implicated in Werner Syndrome, a form of progeria. These mutated nematodes showed significantly reduced lifespans compared to normal counterparts. However, treatment with Telomir-1 restored their longevity to levels comparable to non-mutated specimens. The therapy also improved physiological markers such as movement velocity and tail amplitude, extending healthy lifespan alongside overall longevity.

Dr. Laurent Mouchiroud, Co-founder and CSO of Nagi Bioscience, emphasized the therapy’s transformative potential: “These findings underscore Telomir-1’s ability to counter the decline observed in untreated populations, offering new hope for age-related conditions.”

Understanding Progeria and Accelerated Aging

Progeria, or Hutchinson-Gilford Progeria Syndrome, is a rare genetic disorder causing rapid aging in children. Affecting fewer than 400 individuals globally, the condition leads to severe complications, including cardiovascular issues and premature death.

At its core, progeria results from the accumulation of progerin, a defective protein that accelerates telomere shortening and disrupts cellular processes. Telomeres, the protective caps of chromosomes, naturally shorten with age, but this process is dramatically hastened in progeria, causing widespread cellular dysfunction.

Telomir-1: A Novel Approach

Telomir-1 addresses cellular dysfunction by regulating metal imbalances, reducing oxidative stress, and preventing telomere shortening. Key features of the therapy include:

  • Iron Regulation: Mitigating iron overload to reduce oxidative stress and prevent ferroptosis, a form of cell death linked to accelerated aging.
  • Copper Balancing: Addressing copper imbalances to improve organ function and metabolism, targeting conditions like Wilson’s disease.

These mechanisms support cellular health and longevity, making Telomir-1 a promising candidate for addressing progeria and other age-related diseases.

Broader Applications and Future Research

Beyond progeria, Telomir-1 has shown potential in reversing biological aging, improving insulin resistance in Type 2 diabetes, and regulating copper metabolism in Wilson’s disease.

“Our research validates Telomir-1’s ability to tackle aging at its root,” said Erez Aminov, Chairman and CEO of Telomir. “This therapy represents a novel pathway to treating progeria while exploring broader applications in aging-related conditions.”

Telomir is now preparing for in vitro studies using human progeria cell lines, aiming to further establish Telomir-1’s efficacy in restoring cellular health and normalizing aging processes. This breakthrough could pave the way for transformative therapies addressing the fundamental causes of aging.

Read original press release here

You might like this article:Nvidia Unveils AI and Gaming Innovations at CES 2025

Tags: GrowthLongevityMoversNewsStock MarketTELOTelomir Pharmaceuticals
Previous Post

Nvidia Unveils AI and Gaming Innovations at CES 2025

Next Post

Uber and NVIDIA Partner to Accelerate Autonomous Driving with AI-Powered Solutions

Related Posts

MIRA Pharmaceuticals Secures Key Publication for Ketamir-2, a Next-Gen Ketamine Analog

byLuca Blaumann
June 18, 2025
0

Peer-reviewed journal spotlights differentiated pharmacology and therapeutic promise for neuropathic pain MIRA Pharmaceuticals (MIRA), a clinical-stage biotech firm focused on...

warehouse-2

Ideal Power Signs Strategic Distribution Deal With Kaimei Electronic Corp

byLuca Blaumann
June 10, 2025
0

Partnership with Kaimei Electronic to Promote B-TRAN Technology Across Key Power Electronics Sectors Ideal Power (IPWR), a leading innovator in...

trading-chart-2

Telomir Pharmaceuticals Reports Breakthrough Anti-Aging Results in Preclinical Werner Syndrome Model

byLuca Blaumann
June 5, 2025
0

Lead candidate Telomir-1 reverses aging markers, restores muscle mass, and boosts survival in genetic progeria model Telomir Pharmaceuticals (TELO), a...

Next Post

Uber and NVIDIA Partner to Accelerate Autonomous Driving with AI-Powered Solutions

Latest News

Kroger Shares Surge 9% After Sales Forecast Hike Despite Mixed Quarter

Intel Hires Top Industry Talent to Bolster Engineering and AI Teams

MIRA Pharmaceuticals Secures Key Publication for Ketamir-2, a Next-Gen Ketamine Analog

AMD’s Growth Engine Accelerates as Piper Sandler Raises Price Target to $140

Strategy Doubles Down on Bitcoin with $1.05B Buy Despite Market Jitters

Based on Your Interest

Asset Management

Lloyd Financial CEO & CIO Sees Golden Opportunity in Treasuries and Utilities Amid AI-Driven Deflation

June 13, 2025
Aerospace & Defense

Defense Stocks Rally as Middle East Tensions Escalate Following Israeli Airstrikes

June 13, 2025
code-3
Semiconductors

Oracle Soars on Cloud Optimism and AI Momentum

June 12, 2025

Recommended

Large-Cap

Micron to Invest $30 Billion More in U.S. Semiconductor Expansion

June 12, 2025
Artificial Intelligence

Quantum Computing Stocks Soar After Nvidia CEO’s Bullish Outlook

June 11, 2025
Mega-Cap

Revolutionizing the Barista Experience: Starbucks Rolls Out Generative AI Assistant

June 10, 2025
Electrical Equipment

Ideal Power Signs Strategic Distribution Deal With Kaimei Electronic Corp

June 10, 2025
Brokerages

Circle Stock Soars 300% Post-IPO as Crypto Momentum Accelerates

June 9, 2025
Stoxpo

Follow us on social media:

Highlights

  • Kroger Shares Surge 9% After Sales Forecast Hike Despite Mixed Quarter
  • Intel Hires Top Industry Talent to Bolster Engineering and AI Teams
  • MIRA Pharmaceuticals Secures Key Publication for Ketamir-2, a Next-Gen Ketamine Analog
  • AMD’s Growth Engine Accelerates as Piper Sandler Raises Price Target to $140
  • Strategy Doubles Down on Bitcoin with $1.05B Buy Despite Market Jitters

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

Kroger Shares Surge 9% After Sales Forecast Hike Despite Mixed Quarter

June 20, 2025

Intel Hires Top Industry Talent to Bolster Engineering and AI Teams

June 18, 2025

MIRA Pharmaceuticals Secures Key Publication for Ketamir-2, a Next-Gen Ketamine Analog

June 18, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?